InvestorsHub Logo
Followers 3
Posts 190
Boards Moderated 0
Alias Born 05/16/2013

Re: None

Monday, 10/30/2017 1:09:03 PM

Monday, October 30, 2017 1:09:03 PM

Post# of 427818
I've always felt AMRN's intent in filing with the ITC was more of a move to get FDA to clarify their position, so AMRN could move on to a larger matter, perhaps in the courts.

I don't have any idea what that larger matter may be, but I'm sure AMRN is now moving on to phase b of some sort of a plan. FDA can only stall so long before it is clear to a judge that FDA has done unfair damage to the company. Basically, FDA's admission that it has not yet come to terms on defining modified EPA as a drug is public record - and an omission of failure to fulfill their mission.

AMRN doesn't make these complaints just to be whiners, you know. Personally, I expect AMRN to file some new complaint with the courts in the near future, related to a 1A promotion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News